PRAX - Praxis Precision Medicines GAAP EPS of -$0.71 revenue of $0.68M May, 11 2023 02:05 PM Praxis Precision Medicines Inc. 2023-05-11 14:05:09 ET Praxis Precision Medicines press release ( NASDAQ: PRAX ): Q1 GAAP EPS of -$0.71. Revenue of $0.68M. For further details see: Praxis Precision Medicines GAAP EPS of -$0.71, revenue of $0.68M